No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
LENZ LENZ Therapeutics
- 18.540
- -0.090-0.48%
Close Jun 14 16:00 ET
- 18.000
- -0.540-2.91%
Post 17:31 ET
473.41MMarket Cap-1500P/E (TTM)
19.480High17.890Low127.01KVolume17.890Open18.630Pre Close2.38MTurnover1.32%Turnover RatioLossP/E (Static)25.53MShares24.59052wk High2.39P/B178.28MFloat Cap9.51352wk Low--Dividend TTM9.62MShs Float160.912Historical High--Div YieldTTM8.54%Amplitude7.525Historical Low18.730Avg Price1Lot Size
Full Hours
- 5D
- 1D
- 1W
- 1M
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Why Skye Bioscience Shares Are Trading Lower By 19%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Shares of Skye Bioscience, Inc. (NASDAQ:SKYE) fell sharply during Monday's session after the company announced its SBI-100 Ophthalmic Emulsion Phase 2a trial did not achieve target product profile and
ICC Holdings, Diamond Offshore Drilling, CrowdStrike And Other Big Stocks Moving Higher On Monday
U.S. stocks were mixed, with the Dow Jones index falling around 0.2% on Monday.Shares of ICC Holdings, Inc. (NASDAQ:ICCH) rose sharply during Monday's session.Mutual Capital Group announced plans to a
LENZ Therapeutics to Host Key Opinion Leader Event on June 18, 2024
Capstone data from Phase 3 CLARITY study to be presented Event to feature Key Opinion Leader and Principal Investigator perspectives on LNZ100 potential in presbyopia SAN DIEGO, June 10, 2024 (GLOBE
LENZ Therapeutics to Present at the Jefferies Global Healthcare Conference
SAN DIEGO, May 30, 2024 (GLOBE NEWSWIRE) -- LENZ Therapeutics, Inc. (Nasdaq: LENZ or "LENZ" or the "Company"), a late clinical-stage biopharmaceutical company focused on developing the first aceclid
Sarepta Therapeutics to Replace Shockwave Medical in S&P MidCap 400
Sarepta Therapeutics (SRPT) is set to replace Shockwave Medical (SWAV) in the S&P MidCap 400 effective June 3, according to a late Wednesday statement from S&P Dow Jones Indices. Johnson & Johnson (JN
Cutia Therapeutics' Atopic Dermatitis Drug Advances
Comments
$LENZ Therapeutics(LENZ.US$ $NVIDIA(NVDA.US$
Why the April 19 call option strike @$5 costs only $0.05?
Why the April 19 call option strike @$5 costs only $0.05?
1
$LENZ Therapeutics(LENZ.US$ $Graphite Bio(GRPH.US$
moomoo is very funny, they admitted their display error on the ex dividend date. Then say "the advisory information doesn't serve as investments advice, we are unable to compensate for the economic losses you mentioned"
the story is Moomoo put the wrong ex dividend date causing his clients to sell before the actual ex dividend date then tell clients that " the advisory information doesn't serve as investments advice, so unable to compensate".
...
moomoo is very funny, they admitted their display error on the ex dividend date. Then say "the advisory information doesn't serve as investments advice, we are unable to compensate for the economic losses you mentioned"
the story is Moomoo put the wrong ex dividend date causing his clients to sell before the actual ex dividend date then tell clients that " the advisory information doesn't serve as investments advice, so unable to compensate".
...
$LENZ Therapeutics(LENZ.US$ my situation is weird: they sent my dividend in 21 Mar, but today 26 Mar they withdraw. Any one know this issue?
3
$LENZ Therapeutics(LENZ.US$ hi we need to do class action I didn’t got the dividend they owe me 3,000$
2
8
$LENZ Therapeutics(LENZ.US$ anyone can help? I sell $Graphite Bio(GRPH.US$ on ex dividend date which is 15th but still haven't get dividends yet
2
19
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg